Clinical Trial Update: Pevonedistat and Belinostat in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 1]

View source ↗

Summary

Phase 1 study of pevonedistat in combination with belinostat for relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes was terminated, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• BELEODAQ (BELINOSTAT)
• Pevonedistat (pevonedistat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Acute Myeloid Leukemia, Recurrent Myelodysplastic Syndrome | Phase 1 | Status: TERMINATED | Results posted: 2026-03-03